SEC Form 4 · accession 0001209191-17-021089
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
L Patrick Gage
Director
Period of report
Mar 15, 2017
Accepted (ET)
Mar 16, 2017 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2017 | P | 10,000 | $7.49 | A | 35,000 | D | |
| Common Stock | Mar 15, 2017 | P | 1,000 | $7.47 | A | 3,825 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.